[ad_1]
Jung Eun-kyung, head of Central Defense Countermeasures Headquarters (Bang Dae-bon), said: “At least two or more are currently reviewing the contract with the aim of completing the contract before the end of the year in relation to the negotiations on the pre-purchase of the Corona 19 vaccine on the 14th. “I said.
General Manager Jung answered the related questions in this way at today’s regular briefing.
The government previously announced a total of 44 million vaccines, including 10 million people through the COVAX facility, an international project for the joint purchase and distribution of vaccines, and 34 million through individual negotiations with global pharmaceutical companies. Plans announced to ensure
Among them, four pharmaceutical companies that have already agreed to the advance purchase are the British AstraZeneca, the American Pfizer, Johnson & Johnson, Janssen and Modena.
The contract with AstraZenekawa has now been completed and the purchase quantity has been confirmed through a legally binding agreement with Pfizer, Johnson & Johnson-Jansen (letter of purchase) and Modena (letter of supply).
“We continue to discuss additional quantities with pharmaceutical companies” regarding the government’s quest to secure additional quantities of vaccines in addition to 44 million people. “The additional amount has yet to be confirmed.” Said.
Regarding the fact that the executive director of the Democratic Party, Nak-yeon Lee, said yesterday: ‘We are trying to start vaccinating Corona 19 before March next year,’ he said: ‘The AstraZeneca vaccine (developed) is also produced in Korea and is the best in terms of delivery time. It is expected to be fast, “he said.” Of course, other vaccines are still negotiating the timing of delivery. ”
He continued: “With respect to the approval of the vaccine, the FDA has reviewed the European Union (EU) clinical approval process and the World Health Organization (WHO) verification process and is administered by the Ministry of Health. Food and Drug Safety, and vaccination can be done immediately (when the vaccine is introduced). We are preparing to be together, “he added.
Regarding the development status of the national COVID-19 treatment, Jung said: “I know that we are analyzing data after phase 2 clinical trials for antibody treatments. We believe that the development program will be the fastest.”
He said: “In the case of antibody therapy, if given at the beginning of the outbreak, it is expected to have the effect of preventing ‘severe progression’, leading to severe progression and death.”
(Photo = Yonhap News)
